• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,619.91 1.93
(0.00%)
Dow Jones
7,417.79 59.68
(0.81%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.38 -0.30
(-0.31%)
EUR-INR
110.93 -0.26
(-0.23%)
GBP-INR
128.32 -0.39
(-0.30%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Bazel International Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
539946
INE217E01014
73.2630433
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
7.53
18.71
EPS(TTM)
Face Value()
Div & Yield %
2.53
10
0
 

Shukra Pharmaceuticals reports consolidated net loss of Rs 1.72 crore in the March 2026 quarter
May 08,2026
Net loss of Shukra Pharmaceuticals reported to Rs 1.72 crore in the quarter ended March 2026 as against net profit of Rs 5.39 crore during the previous quarter ended March 2025. Sales declined 52.37% to Rs 6.32 crore in the quarter ended March 2026 as against Rs 13.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 130.27% to Rs 22.06 crore in the year ended March 2026 as against Rs 9.58 crore during the previous year ended March 2025. Sales rose 74.07% to Rs 56.73 crore in the year ended March 2026 as against Rs 32.59 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.3213.27 -52 56.7332.59 74
OPM %11.0855.09 -50.6639.06 -
PBDT1.398.51 -84 32.2316.34 97
PBT0.387.57 -95 28.7913.34 116
NP-1.725.39 PL 22.069.58 130